Alterations of the expression of TET2 and DNA 5-hmC predict poor prognosis in Myelodysplastic Neoplasms

Alterations of the expression of TET2 and DNA 5-hmC predict poor prognosis in Myelodysplastic Neoplasms

Abstract Background Myelodysplastic Neoplasms (MDS) are clonal stem cell disorders characterized by ineffective hematopoiesis and progression to acute myeloid leukemia, myelodysplasia-related (AML-MR). A major mechanism of pathogenesis of MDS is the aberration of the epigenetic landscape of the hema...

Full description

Bibliographic Details
Main Authors:	Ashikh A. Seethy, Karthikeyan Pethusamy, Tushar Kushwaha, Gaurav Kumar, Joyeeta Talukdar, Rekha Chaubey, Udayakumar Dharmalingam Sundaram, Manoranjan Mahapatra, Renu Saxena, Ruby Dhar, Krishna K. Inampudi, Subhradip Karmakar
Format:	Article
Language:	English
Published:	BMC 2023-10-01
Series:	BMC Cancer
Subjects:	Myelodysplastic neoplasms Myelodysplastic syndrome AML-myelodysplasia related Acute myeloid leukemia with myelodysplasia related changes Epigenetics TET2 protein
Online Access:	https://doi.org/10.1186/s12885-023-11449-2

Similar Items

Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
by: Mohammad Faizan Zahid, et al.
Published: (2016-12-01)

Histiocytoid Sweet’s syndrome in a patient with myelodysplastic syndrome: report and review of the literature
by: Michael M. Shalaby, et al.
Published: (2016-01-01)

Secondary dysmyelopoiesis in patients with myelodysplastic syndromes: A review of literature and the authors' data
by: V N Dvirnyk, et al.
Published: (2014-07-01)

The miRNA Profile in Non-Hodgkin’s Lymphoma Patients with Secondary Myelodysplasia
by: Yuliya Andreevna Veryaskina, et al.
Published: (2020-10-01)

Raising the standards of patient‐centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS‐RIGHT project
by: Fabio Efficace, et al.
Published: (2023-03-01)

GATA2 mutation in long stand Mycobacterium kansasii infection, myelodysplasia and MonoMAC syndrome: a case-report
by: Daniela Palheiro Mendes-de-Almeida, et al.
Published: (2019-04-01)

Simultaneous myelodisplasia and multiple myeloma successfully treated with lenalidomide
by: Alessandro Gozzetti, et al.
Published: (2014-08-01)

Defining the mutational profile of lower-risk myelodysplastic neoplasm patients with respect to disease progression using next-generation sequencing and pyrosequencing
by: Monika Adamska, et al.
Published: (2024-02-01)

Bilateral Vocal Cord Palsy with Arnold Chiari Malformation: A Rare Case Series
by: Nikhil Arora, et al.
Published: (2016-09-01)

Immune Dysfunction, Cytokine Disruption, and Stromal Changes in Myelodysplastic Syndrome: A Review
by: Olivia F. Lynch, et al.
Published: (2022-02-01)

Localized ecthyma gangrenosum without sepsis in a neutropenic patient with a myelodysplastic syndrome—Refractory anemia with excess blasts type 2
by: Anaïs Zanella, et al.
Published: (2019-09-01)

TET2 Expression in Bone Marrow Mononuclear Cells of Patients with Myelodysplastic Syndromes and Its Clinical Signifcances
by: Wei Zhang, et al.
Published: (2012-03-01)

TET2 Expression in Bone Marrow Mononuclear Cells of Patients with Myelodysplastic Syndromes and Its Clinical Significance
by: Wei Zhang, et al.
Published: (2012-03-01)

Síndrome mielodisplásica na infância Myelodysplastic syndromes in childhood
by: Luiz F. Lopes, et al.
Published: (2006-09-01)

A rare case of myelodysplastic syndrome with refractory thrombocytopenia
by: Waqas Jehangir, et al.
Published: (2015-09-01)

Cytogenetic study of Brazilian patients with myelodysplastic syndrome (MDS)
by: Tamara Borgonovo, et al.
Published: (2005-12-01)

New Insights on Iron Study in Myelodysplasia
by: Noha M. El Husseiny, et al.
Published: (2014-12-01)

Leishmaniasis presenting as myelodysplasia: A diagnostic dilemma
by: Amita Jain Gupta, et al.
Published: (2018-01-01)

Progressive transfusion and growth factor independence with adjuvant sertraline in low risk myelodysplastic syndrome treated with an erythropoiesis stimulating agent and granulocyte-colony stimulating factor
by: Kirtan Nautiyal, et al.
Published: (2015-01-01)

Favourable prognostic factors in therapy related acute myeloid leukaemia
by: Antonijević Nebojša, et al.
Published: (2011-01-01)

Is dynamic thiol/disulfide homeostasis associated with the prognosis of myelodysplastic syndrome?
by: Ali Ucar Mehmet, et al.
Published: (2020-01-01)

Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
by: Guru Subramanian Guru Murthy, et al.
Published: (2024-01-01)

February 2024 Medical Image of the Month: Pulmonary Alveolar Proteinosis in Myelodysplastic Syndrome
by: Parker Brown MD, et al.
Published: (2024-02-01)

TET Enzymes and 5hmC Levels in Carcinogenesis and Progression of Breast Cancer: Potential Therapeutic Targets
by: Eric Genaro Salmerón-Bárcenas, et al.
Published: (2023-12-01)

Clinical Characteristics and Optimal Therapy of Acute Myeloid Leukemia with Myelodysplasia-Related Changes: A Retrospective Analysis of a Cohort of Chinese Patients
by: Lei Wang, et al.
Published: (2021-08-01)

Jumping translocations of chromosome 1q occurring by a multi-stage process in an acute myeloid leukemia progressed from myelodysplastic syndrome with a TET2 mutation
by: Ina Lee, et al.
Published: (2019-11-01)

Clinical Risk Factors for Extended Spectrum B-lactamase-producing Bacteriuria in Children with Myelodysplasia Performing Clean Intermittent Catheterization
by: Tuncay Toprak, et al.
Published: (2020-06-01)

Pre-analytical parameters associated with unsuccessful karyotyping in myeloid neoplasm: a study of 421 samples
by: M.F.M. Santos, et al.
Published: (2019-02-01)

AML with Myelodysplasia-Related Changes: Development, Challenges, and Treatment Advances
by: Kristin L. Koenig, et al.
Published: (2020-07-01)

Multilineage Dysplasia as Assessed by Immunophenotype in Acute Myeloid Leukemia: A Prognostic Tool in a Genetically Undefined Category
by: Francesco Mannelli, et al.
Published: (2020-10-01)

TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
by: Ramy Rahmé, et al.
Published: (2023-04-01)

Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes
by: João Agostinho Machado-Neto, et al.
Published: (2011-01-01)

Increased Apoptotic Activity in Low-Risk Myelodysplastic Syndrome
by: Songyi Park, et al.
Published: (2022-08-01)

Risk Factors Predicting Upper Urinary Tract Damage in Patients With Myelodysplasia: Data Analysis of 637 Cases From A Single Center
by: Han Deng, et al.
Published: (2022-02-01)

ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia‐related changes and normal karyotype
by: Concepción Prats‐Martín, et al.
Published: (2020-06-01)

Case Report: VEXAS Syndrome: From Mild Symptoms to Life-Threatening Macrophage Activation Syndrome
by: Frederik Staels, et al.
Published: (2021-04-01)

Aberrant Alternative Splicing in U2af1/Tet2 Double Mutant Mice Contributes to Major Hematological Phenotypes
by: Cristina Martínez-Valiente, et al.
Published: (2021-06-01)

Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome
by: Amrita Goyal, MD, et al.
Published: (2022-05-01)

Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case?
by: Mirko Farina, et al.
Published: (2020-10-01)

Evaluation of Peripheral Blood Smear for Myelodysplasia in Breast Cancer Patients who Received Adjuvant Antracycline
by: Hasan Mutlu, et al.
Published: (2011-12-01)